Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 2,601–2,650 of 2,679 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06245330	A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	180	Ascentawits Pharmaceuticals, LtdINDUSTRY	1	Feb 7, 2024	clinicaltrials
NCT06246162	Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma	recruiting	Phase 1 / Phase 2	30	Affiliated Hospital of Nantong UniversityOTHER	1	Feb 7, 2024	clinicaltrials